StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.89+0.02 (+0.52%)

Close on Nov 18, 2026Market cap $161.81MP/E 0.9Yield 6.43%

Oramed Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Oramed Pharmaceuticals's price to sales ratio was 76.2× on Apr 30, 2026, against 50.1× a year earlier. Over the last 5 years it ranged from 19.6× to 305.7×, with a median of 59.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202676.2×+6.4
2024Apr 30, 202469.8×+35.4
2023Dec 29, 202334.4×−122.7
2022Dec 30, 2022157.1×−29.4
2021Dec 31, 2021186.5×+149.4
2020Dec 31, 202037.0×+3.9
2019Dec 31, 201933.1×+11.8
2018Dec 31, 201821.3×−28.8
2017Dec 29, 201750.1×−75.8
2016Dec 30, 2016125.9×–

More Oramed Pharmaceuticals figures

See a number that looks wrong?